Global Cell-based Assays Technologies and Markets, 2015-2017 & 2021

Dublin, Oct. 18, 2017 -- The "Cell-based Assays: Technologies and Global Markets" report has been added to Research and Markets' offering.

The Global Market for Cell-Based Assays is Expected to Increase from $17.1 Billion in 2016 to Nearly $28.4 Billion in 2021 at a CAGR of 10.6%

Report Includes

• An overview of the global markets and related technologies for cell-based assays.
• Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
• Examinations of major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.
• The current market status of cell-based assays in terms of strengths, weaknesses, opportunities and threats facing various assays and developments already on the market.
• Discussion of current issues and trends affecting the industry, and costs and other factors influencing demand.
• Coverage of new technologies, trends, alliances, and mergers.
• Profiles of major players in the industry.

This report is an update on the earlier report: Cell-based Assays: Technologies and Global Markets. It reviews global markets for cell-based assays and new developments and forecasts trends for use of these assays for drug discovery, safety and toxicology through 2021. The report includes important assays, technologies and the latest developments and market share by assay type and company, with a special emphasis on the U.S. market. Statistical information on the types of cancers prevalent worldwide is also included.

The report also includes current issues and trends affecting the industry, costs and factors influencing demand. It covers products in development, new technologies, trends, and alliances and mergers. The report offers market data by segment and region. It also provides market trends with respect to drivers, restraints and opportunities.

Key Topics Covered:

1: Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Intended Audience
• Methodology
• Geographic Breakdown

2: Summary and Highlights

3: Overview

• Introduction
• Drug Discovery
• Overview: Cell-based Assays
• Tools for Drug Discovery

4: Assays for Drug Discovery

• Cell-based Approaches for ADME/Tox Screening
• Conclusions

5: Cell-based Assays: Current Technologies

• Factors in Cell-based Assay Development
• Reporter Gene Technology
• Cell-based Assays for Studying Protein-Protein Interactions
• Cell-based Protein-Fragment Complementation Assays
• Measuring Calcium Signaling
• Cell-based Label-free Approaches
• Automation and Miniaturization
• Cell Patterning
• Cell-based Assays and Physiological Relevance
• Cell-based Assays and Multiplexing
• Ultra-high-throughput Screening
• Development of PathHunter Assay
• High-content Screening Technology
• Investigational New Drug (IND) Studies in Drug Development
• Prodrug Strategies
• Molecular Modeling
• Summary
• New Technologies
• Conclusion

6: Commercialization of Cell-based Assays

• Role of Cell-based Assays
• Summary

7: Global Cell-based Assay and Instrumentation Market

• Current Market Overview
• Cell-based Assays
• Cell-based Assay Market
• Cell Biology Reagents
• High-throughput Screening
• Drug Discovery Technology Market
• Market for Life Sciences Tools and Reagents
• Cell Culture Market
• Global Market for Cell Culture Reagents
• Cell-based Assays Market Growth
• Cell-based Assays: Basic Research
• Market for Cellular Assays in Basic Research
• ADME and Toxicology Market
• Cell-based Assays for Drug Discovery
• ADME-Toxicology Testing Market
• Types of Cell-based Assays
• High-content Screening Instrumentation Market
• Label-free Detection Market
• Microplate Instrumentation and Supplies
• Challenges with Cell-based Assays
• Future of Cell-based Assays
• Cell-based Assays for Research Purposes
• Cell-based Assays: Screening Ion Channels
• Label-free Detection
• Conclusion

8: Global Regional Markets

• Global Market for Cell-based Assays
• Summary
• U.S. Market
• Global Market Overview
• European Market
• Drug Discovery in the Emerging Economies
• Advances in Cell-based Assays

9: Company Profiles

• Acea Biosciences
• BD Biosciences
• Beckman Coulter
• Cellular Dynamics International
• Caliper Life Sciences
• Celsis In Vitro Technologies (Celsis Ivt)
• Cisbio Bioassays
• Discoverx Corp.
• EMD Millipore
• Enzo Life Sciences
• Endonovo Therapeutics
• Evotec AG
• Ge Healthcare
• Hemogenix
• Life Technologies
• Lonza
• Molecular Devices (Danaher)
• Oncolmmunin
• Origene Technologies
• Perkinelmer
• Promega Corp.
• Roche Group
• Stemcells Inc.
• Thermo Fisher Scientific
• TTP Labtech
• Vivo Biosciences
• Vitro Biopharma

10: Legal Aspects of Cell-based Assays
Intellectual Property Landscape for Cell-based Assays

11: Appendix: Bibliography

For more information about this report visit https://www.researchandmarkets.com/research/8h4pks/cellbased

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Biotechnology